Who
Carlo Incerti
Director
Company insider
Files Form 4 as: Director, Dyne Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $474K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 2 Mar 2022
- Last trade
- 5 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 9 Jun 2026 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,152 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,152 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 18 Nov 2024filed 18 Nov 2024 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,500 at $0.00 | filing |
| 18 Nov 2024filed 18 Nov 2024 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Code M | $143K16,500 at $8.69 | filing |
| 18 Nov 2024filed 18 Nov 2024 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $474K16,500 at $28.73 | filing |
| 22 May 2024filed 24 May 2024 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,133 at $0.00 | filing |
| 24 May 2023filed 25 May 2023 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,900 at $0.00 | filing |
| 2 Mar 2022filed 4 Mar 2022 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,193 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.